Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 102201 - 102220 out of 493827 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Colombia | (L01XC24) daratumumab | DARZALEX 20 MG/ML | 1, 20mg , CADA ML DE CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN / JANSSENCILAGS.A. |
| Colombia | (L01XC24) daratumumab | DARZALEX 20 MG/ML | 1, 20mg , CADA ML DE CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN / JANSSENCILAGS.A. |
| Colombia | (L01XC28) durvalumab | IMFINZI® 50 MG/ML CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN | 1, 50mg , ML | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECA / ASTRAZENECACOLOMBIAS.A.S |
| Colombia | (L01XC28) durvalumab | IMFINZI® 50 MG/ML CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN | 1, 50mg , ML | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECA / ASTRAZENECACOLOMBIAS.A.S |
| Colombia | (L01XC28) durvalumab | IMFINZI® 50 MG/ML CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN | 1, 50mg , ML | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECA / ASTRAZENECACOLOMBIAS.A.S |
| Colombia | (L01XC28) durvalumab | IMFINZI® 50 MG/ML CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN | 1, 50mg , ML | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECA / ASTRAZENECACOLOMBIAS.A.S |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 30, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 180, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 60, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 120, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 180, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 30, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 60, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 120, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 180, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 100 MG COMPRIMIDOS CON CUBIERTA PELICULAR | 180, 100mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G.PHARMACEUTICALOPERATIONSSCHEWEIZ |
| Colombia | (L01XE01) imatinib | GLIVEC® 400 MG COMPRIMIDO CON CUBIERTA PELICULAR | 30, 400mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G. |
| Colombia | (L01XE01) imatinib | GLIVEC® 400 MG COMPRIMIDO CON CUBIERTA PELICULAR | 60, 400mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G. |
| Colombia | (L01XE01) imatinib | GLIVEC® 400 MG COMPRIMIDO CON CUBIERTA PELICULAR | 120, 400mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G. |
| Colombia | (L01XE01) imatinib | GLIVEC® 400 MG COMPRIMIDO CON CUBIERTA PELICULAR | 180, 400mg , COMPRIMIDO CON CUBIERTA PELICULAR | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NOVARTIS / NOVARTISPHARMAA.G. |
Pages
